AstraZeneca in $560 m deal for respiratory firm
British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.
Join the discussion below, or Read more at Seattle Times.
Since: Apr 13
#1 Jun 10, 2013
This sounds promising.
Add your comments below
|Review: Senior Helpers (Mar '16)||Fri||John A||3|
|Re-Elect Judge Aaron Persky!||Sep 7||Big Lumber||8|
|White Male Privilege||May '16||It is True||4|
|Beltramo's Wines & Spirits is closing its doors...||May '16||Lindy||1|
|LA Times Completely Botches Story on HSR Fares (May '15)||May '15||cbloom57||1|
|City Blows the Whistle on High-Speed Trains (Feb '15)||Feb '15||CTYKE||1|
|Bill Widmer named new Rancho Palos Verdes city ... (Dec '14)||Dec '14||Are you serious||1|
Find what you want!
Search Atherton Forum Now
Copyright © 2016 Topix LLC